Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Bruce I. Shnider"'
Autor:
Samuel Taylor, Melvin J. Krant, Bruce I. Shnider, Joseph Scotto, Marvin A. Schneiderman, Oleg S. Selawry, John Edmonson, Kenneth Olson, Elias Kazam, James Holland
Publikováno v:
Cancer. 40:4-8
Two hundred thirty-nine patients with microscopically proven, inoperable bronchogenic carcinoma were allocated at random to receive twice weekly I.M. injections of either methotrexate at "high dose" of 0.06 mg/kg/dose or methotrexate at "low dose" of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf366c7f3048dd9a436d9a0824d31355
https://doi.org/10.1002/1097-0142(197707)40:1<4::aid-cncr2820400103>3.0.co
https://doi.org/10.1002/1097-0142(197707)40:1<4::aid-cncr2820400103>3.0.co
Autor:
Thomas C. Hall, Stuart J. Pocock, John Horton, Jacob Colsky, Richard A. Oberfield, Harvey Brodovsky, Bruce I. Shnider
Publikováno v:
Medical and Pediatric Oncology. 5:231-240
A controlled trial of high-intermittent vs low-chronic dose cyclophosphamide in human lung cancer failed to show the benefits reported in noncontrolled trials. There were no differences in toxicity observed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e925677bb05929af45e3f64bb0a9d5c5
https://doi.org/10.1002/mpo.2950050132
https://doi.org/10.1002/mpo.2950050132
Autor:
James A. Hanley, Pierre R. Band, William Regelson, Colsky J, Bruce I. Shnider, Arnold Mittelman, Elias Eg
Publikováno v:
Oncology. 31:273-279
53 patients with intractable malignant diseases that were treated with a new alkylating agent, 4-N, N-bis (2-chloroethyl) amino phenyl N (P-carboxyphenyl) carbamate, also known as ‘IC-140’ were evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f17804f87cdaaab4c809c12cd2d5ba04
https://doi.org/10.1159/000225033
https://doi.org/10.1159/000225033
Autor:
John Horton, Leo L. Stolbach, Bruce I. Shnider, Stuart Pocock, Sherwood P. Miller, Seymour Brenner
Publikováno v:
Cancer. 36:1625-1630
In a study conducted by the Eastern Cooperative Oncology Group, 51 evaluable women with advanced ovarian carcinoma were randomized to either abdominal radiation therapy alone, chlorambucil alone, or to a combination of radiation therapy and chlorambu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e47c780b2d7b9a2173f023dbb3944ccc
https://doi.org/10.1002/1097-0142(197511)36:5<1625::aid-cncr2820360515>3.0.co
https://doi.org/10.1002/1097-0142(197511)36:5<1625::aid-cncr2820360515>3.0.co
Publikováno v:
Medical and Pediatric Oncology. 1:113-121
Sixty patients with metastatic or primary inoperable breast cancer not suitable for hormone alteration therapy were blindly randomized between weekly 5-fluorouracil, intravenously, and daily physiologic doses of conjugated estrogens by mouth against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47eecb1dd7a952f1fb34c1a089d69f68
https://doi.org/10.1002/mpo.2950010206
https://doi.org/10.1002/mpo.2950010206
Autor:
Ross L. Prentice, Paul P. Carbone, Bruce I. Shnider, Raymond E. Lenhard, Coston W. Berard, Leo L. Stolbach, John Horton, Albert H. Owens, Richard F. Bakemeier
Publikováno v:
Cancer. 38:1052-1059
The Eastern Cooperative Oncology Group has studied 113 patients with generalized progressive malignant lymphomas in a randomized clinical trial. Pathologic diagnosis was subclassified by cell type and nodal pattern by The Pathology Panel for Lymphome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c380de054ce8f20acfbc74303d6f2e4
https://doi.org/10.1002/1097-0142(197609)38:3<1052::aid-cncr2820380303>3.0.co
https://doi.org/10.1002/1097-0142(197609)38:3<1052::aid-cncr2820380303>3.0.co
Publikováno v:
Medical and Pediatric Oncology. 5:15-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97f4f92cdbefa460e1828c3b3358d99
https://doi.org/10.1002/mpo.2950050104
https://doi.org/10.1002/mpo.2950050104
Autor:
D. Willems, Pierre R. Band, M. Verhelst, William Regelson, Charles Gurchot, Frances E. Bull, Bruce I. Shnider, Colsky J, K.M. Anderson, J. Van Ryzin, Scot E. Moss, Wilhelm G. Doos, Anastasios A. Mihas, I.S. Mendelson, Joseph R. Bateman, Itzhak S. Levij, Arnold Mittelman, Thomas F. Pajak, A.J. Weiss, David M. Rubin, Hubertine Heremans, W.L. Wilson, Elias Eg, Robert Frelick, James A. Hanley, David C. Stolinsky, Jean-Jacques Cassiman, Alfons Billiau
Publikováno v:
Oncology. 31:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9563cce78529d21932ecb895a54bd4b3
https://doi.org/10.1159/000225031
https://doi.org/10.1159/000225031
Publikováno v:
Cancer. 31:1287-1297
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6fde2f133007e7abf5d13bda1bab341
https://doi.org/10.1002/1097-0142(197305)31:5<1287::aid-cncr2820310537>3.0.co
https://doi.org/10.1002/1097-0142(197305)31:5<1287::aid-cncr2820310537>3.0.co
Publikováno v:
Clinical Pharmacology & Therapeutics. 12:833-837
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec9a04622ba3de8694447db97dae996
https://doi.org/10.1002/cpt1971125833
https://doi.org/10.1002/cpt1971125833